These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27069866)

  • 1. Insulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production.
    Lee YS; De Vadder F; Tremaroli V; Wichmann A; Mithieux G; Bäckhed F
    Mol Metab; 2016 Apr; 5(4):263-270. PubMed ID: 27069866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective stimulation of colonic L cells improves metabolic outcomes in mice.
    Lewis JE; Miedzybrodzka EL; Foreman RE; Woodward ORM; Kay RG; Goldspink DA; Gribble FM; Reimann F
    Diabetologia; 2020 Jul; 63(7):1396-1407. PubMed ID: 32342115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1R signaling modulates colonic energy metabolism, goblet cell number and survival in the absence of gut microbiota.
    Greiner TU; Koh A; Peris E; Bergentall M; Johansson MEV; Hansson GC; Drucker DJ; Bäckhed F
    Mol Metab; 2024 May; 83():101924. PubMed ID: 38521185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune System Effects of Insulin-Like Peptide 5 in a Mouse Model.
    Vahkal B; Yegorov S; Onyilagha C; Donner J; Reddick D; Shrivastav A; Uzonna J; Good SV
    Front Endocrinol (Lausanne); 2020; 11():610672. PubMed ID: 33519716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like peptide 5 is an orexigenic gastrointestinal hormone.
    Grosse J; Heffron H; Burling K; Akhter Hossain M; Habib AM; Rogers GJ; Richards P; Larder R; Rimmington D; Adriaenssens AA; Parton L; Powell J; Binda M; Colledge WH; Doran J; Toyoda Y; Wade JD; Aparicio S; Carlton MB; Coll AP; Reimann F; O'Rahilly S; Gribble FM
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11133-8. PubMed ID: 25028498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INSL5 activates multiple signalling pathways and regulates GLP-1 secretion in NCI-H716 cells.
    Ang SY; Evans BA; Poole DP; Bron R; DiCello JJ; Bathgate RAD; Kocan M; Hutchinson DS; Summers RJ
    J Mol Endocrinol; 2018 Apr; 60(3):213-224. PubMed ID: 29535183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic expression of lipopolysaccharide-binding protein (Lbp) is induced by the gut microbiota through Myd88 and impairs glucose tolerance in mice independent of obesity.
    Molinaro A; Koh A; Wu H; Schoeler M; Faggi MI; Carreras A; Hallén A; Bäckhed F; Caesar R
    Mol Metab; 2020 Jul; 37():100997. PubMed ID: 32305515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Antagonist Peptide Reveals a Physiological Role of Insulin-Like Peptide 5 in Control of Colorectal Function.
    Pustovit RV; Zhang X; Liew JJ; Praveen P; Liu M; Koo A; Oparija-Rogenmozere L; Ou Q; Kocan M; Nie S; Bathgate RA; Furness JB; Hossain MA
    ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1665-1674. PubMed ID: 34661082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial modulation of energy availability in the colon regulates intestinal transit.
    Wichmann A; Allahyar A; Greiner TU; Plovier H; Lundén GÖ; Larsson T; Drucker DJ; Delzenne NM; Cani PD; Bäckhed F
    Cell Host Microbe; 2013 Nov; 14(5):582-90. PubMed ID: 24237703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colokinetic effect of an insulin-like peptide 5-related agonist of the RXFP4 receptor.
    Diwakarla S; Bathgate RAD; Zhang X; Hossain MA; Furness JB
    Neurogastroenterol Motil; 2020 May; 32(5):e13796. PubMed ID: 31989750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ-free mice are not protected against diet-induced obesity and metabolic dysfunction.
    Moretti CH; Schiffer TA; Li X; Weitzberg E; Carlström M; Lundberg JO
    Acta Physiol (Oxf); 2021 Mar; 231(3):e13581. PubMed ID: 33222397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INSL5-deficient mice display an alteration in glucose homeostasis and an impaired fertility.
    Burnicka-Turek O; Mohamed BA; Shirneshan K; Thanasupawat T; Hombach-Klonisch S; Klonisch T; Adham IM
    Endocrinology; 2012 Oct; 153(10):4655-65. PubMed ID: 22822165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography/mass spectrometry based detection and semi-quantitative analysis of INSL5 in human and murine tissues.
    Kay RG; Galvin S; Larraufie P; Reimann F; Gribble FM
    Rapid Commun Mass Spectrom; 2017 Dec; 31(23):1963-1973. PubMed ID: 28857318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system.
    Schéle E; Grahnemo L; Anesten F; Hallén A; Bäckhed F; Jansson JO
    Endocrinology; 2013 Oct; 154(10):3643-51. PubMed ID: 23892476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulinotrophic effect of insulin-like peptide 5 in vitro and in vivo.
    Luo X; Li T; Zhu Y; Dai Y; Zhao J; Guo ZY; Wang MW
    Biochem J; 2015 Mar; 466(3):467-73. PubMed ID: 25514935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviewing the physiological roles of the novel hormone-receptor pair INSL5-RXFP4: a protective energy sensor?
    Hechter D; Vahkal B; Tiede T; Good SV
    J Mol Endocrinol; 2022 May; 69(1):R45-R62. PubMed ID: 35521762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility.
    Yang M; Fukui H; Eda H; Xu X; Kitayama Y; Hara K; Kodani M; Tomita T; Oshima T; Watari J; Miwa H
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G367-G373. PubMed ID: 28154011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function relationship of murine insulin-like peptide 5 (INSL5): free C-terminus is essential for RXFP4 receptor binding and activation.
    Belgi A; Hossain MA; Shabanpoor F; Chan L; Zhang S; Bathgate RA; Tregear GW; Wade JD
    Biochemistry; 2011 Oct; 50(39):8352-61. PubMed ID: 21866895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
    Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
    Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.